This site is intended for Healthcare professionals only.

Lupin gets UK MHRA approval for Goa facility


Lupin gets UK MHRA approval for Goa facility

New Delhi: Pharma major Lupin announced that it has received approval from the UK health regulator for its Goa facility.

Lupin in a regulatory filing said, “it has received approval from UK MHRA (United Kingdom’s Medicines and Healthcare products Regulatory Agency) for its Goa facility.

Commenting on the development, Nilesh Gupta, Managing Director – Lupin said, “The outcome of this inspection is a positive and encouraging sign for us, and is a testament to our commitment to maintain global manufacturing standards and best practices. This approval from UK MHRA is a significant development for our Goa plant.”



Source: With Agency Inputs
0 comment(s) on Lupin gets UK MHRA approval for Goa facility

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted